News

Seniors should skip this vaccine after deadly complications, FDA warns
The CDC recommends the vaccine pause while it investigates “serious adverse events,” including neurologic and cardiac events.
After 2 reported deaths, officials tell Ixchiq users age 60+ to stop vaccine temporarily
The Trump administration's FDA and CDC is advising U.S. patients using the drug Ixchiq to hold off while U.S. health ...
MedPage Today1d
FDA/CDC Call Time Out on Ixchiq Vaccine for Older Adults
Hold off on inoculating people ages 60 and older against chikungunya infection with the Ixchiq vaccine, the FDA and CDC ...
U.S. Advises Older Travelers to Avoid Chikungunya Vaccine
TUESDAY, May 13, 2025 (HealthDay News) — U.S. health officials are telling travelers aged 60 and older to avoid a chikungunya ...
FDA warns seniors to avoid this vaccine after deadly complications
Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...
BioPharma Dive2d
FDA follows EMA in limiting use of Valneva shot
Reports of severe adverse events in some people who received the chikungunya vaccine have spurred regulators in Europe and ...
Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United States
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the U.S. Food and Drug Association (FDA) and the U.S. Centers for Disease Control and Prevention (CDC) ...
Valneva SE: Still Undervalued Travel Vaccine Bet With Robust 2025 Guidance
Valneva SE offers exposure to a robust travel vaccine portfolio that includes Ixiaro, Dukoral, and Ixchiq. Read what ...